Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Surgical Procedures, Operative × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Sarcoma 4 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Glioblastoma 3 Breast Neoplasms 3 Stomach Neoplasms 2 Recurrence 2 Neoplasms 2 Melanoma 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymic epithelial tumor 1 Sinonasal Squamous Cell Carcinoma 1 Sarcoma, Ewing 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pilonidal Sinus 1 Patient Preference 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1

Interventions

Specimen Handling 37 pembrolizumab 35 Biopsy 33 Magnetic Resonance Spectroscopy 27 Nivolumab 18 Paclitaxel 13 trastuzumab deruxtecan 10 Gemcitabine 10 Fulvestrant 10 Capecitabine 10 Radiosurgery 9 Irinotecan 9 Ipilimumab 9 Cyclophosphamide 9 Carboplatin 9 Taxes 8 Pemetrexed 8 Leucovorin 8 Fluorouracil 8 Cetuximab 8 atezolizumab 7 Drug Therapy 7 Cisplatin 7 130-nm albumin-bound paclitaxel 7 abemaciclib 6 Oxaliplatin 6 palbociclib 5 olaparib 5 fludarabine 5 aldesleukin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05717166 2025-12-31

SABR-SYNC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡